Abiopharma

🔍 LEONARD JOHN M (Executive)

Company: Intellia Therapeutics, Inc. (NTLA)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 19,890 shares of Common Stock at $12.6 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 1,149,849.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,785 shares of Common Stock at $13.0 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 1,147,064.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 58,415.00 | Footnotes: F3

Footnotes:

• F1: The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 to $13.00, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 20, 2026 at each separate price.
• F3: Shares held by the John M. Leonard 2015 Irrevocable Trust.